Evidence map›Paper›PMID 29272994›Full record

ArticleBMC medical research methodology2017

What's the uptake? Pragmatic RCTs may be used to estimate uptake, and thereby population impact of interventions, but better reporting of trial recruitment processes is needed.

Katy J L Bell, Amanda McCullough, Chris Del Mar, Paul Glasziou

Open access · goldAbstract read
In one paragraph

Article in BMC medical research methodology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Katy J L BellSchool of Public Health, The University of Sydney, Camperdown, NSW, 2006, Australia. katy.bell@sydney.edu.au.
Amanda McCulloughCentre for Research in Evidence Based Practice (CREBP), Bond University, Gold coast, QLD, 4229, Australia.
Chris Del MarCentre for Research in Evidence Based Practice (CREBP), Bond University, Gold coast, QLD, 4229, Australia.
Paul GlasziouCentre for Research in Evidence Based Practice (CREBP), Bond University, Gold coast, QLD, 4229, Australia.
Bond University · AUUniversity of Sydney · AU

Funding

Australian National Health and Medical Research Council 1044904Australian National Health and Medical Research Council 527500Australian National Health and Medical Research Council (NHMRC) 1013390
6 · The paper itself

Abstract

backgroundEffectiveness of interventions in pragmatic trials may not translate directly into population impact, because of limited uptake by clinicians and/or the public. Uptake of an intervention is influenced by a number of factors.

methodsWe propose a method for calculating population impact of clinical interventions that accounts for the intervention uptake. We suggest that population impact may be estimated by multiplying the two key components: (1) the effectiveness of the intervention in pragmatic trials (trial effect); and, (2) its uptake in clinical practice. We argue that participation rates in trials may be a valid proxy for uptake in clinical practice and, in combination with trial effectiveness estimates, be used to rank interventions by their likely population impact. We illustrate the method using the example of four interventions to decrease antibiotic prescription for acute respiratory infections in primary care: delayed prescribing, procalcitonin test, C-Reactive Protein, shared decision making.

resultsIn order to estimate uptake of interventions from trial data we need detailed reporting on the recruitment processes used for clinician participation in the trials. In the antibiotic prescribing example, between 75 and 91% of the population would still be prescribed or consume antibiotics because effective interventions were not taken up. Of the four interventions considered, we found that delayed prescribing would have the highest population impact and shared decision making the lowest.

conclusionEstimates of uptake and population impact of an intervention may be possible from pragmatic RCTs, provided the recruitment processes for these trials are adequately reported (which currently few of them are). Further validation of this method using empirical data on intervention uptake in the real world would support use of this method to decide on public funding of interventions.

Indexed as

Patient ParticipationPractice Patterns, Physicians'Acute DiseaseAnti-Bacterial AgentsCalcitoninCommunicationC-Reactive ProteinDecision MakingHumansOutcome Assessment, Health CarePragmatic Clinical Trials as TopicPrimary Health CareRespiratory Tract InfectionsTime FactorsAnti-Bacterial AgentsCalcitoninC-Reactive ProteinDrug resistance, microbialHealth policyMethodsPragmatic clinical trialPrimary health carePublic health

Identifiers

PMID29272994
PMCPMC5741884
OpenAlexW2777239828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.